American Heart Journal
Volume 148, Issue 6 , Pages 1020-1027 , December 2004

Clinical trial–derived risk model may not generalize to real-world patients with acute coronary syndrome

  • Andrew T. Yan, MD

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Philip Jong, MD, PhD

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Raymond T. Yan, MASc, MD

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Mary Tan, BSc

      Affiliations

    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • ,
  • David Fitchett, MD

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Chi-Ming Chow, MD, MSc

      Affiliations

    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Matthew T. Roe, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • ,
  • Karen S. Pieper, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC, USA
    • ,
  • Anatoly Langer, MD, MSc

      Affiliations

    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Shaun G. Goodman, MD, MSc

      Affiliations

    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests: Dr Shaun G. Goodman, St Michael's Hospital, Division of Cardiology, 30 Bond St, Room 4–072 Queen, Toronto, Ontario, Canada M5B 1W8.
    • ,
  • for the Canadian Acute Coronary Syndromes (ACS) Registry Investigators

      Affiliations

    • Canadian Heart Research Centre, Toronto, Ontario, Canada
    • Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada
    • Duke Clinical Research Institute, Durham, NC, USA

Received 10 December 2003 ,Accepted 13 February 2004.

References 

  1. Cannon CP, Weintraub WS, Demopoulos LA, et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879–1887
  2. Morrow DA, Antman EM, Snapinn SM, et al.  An integrated clinical approach to predicting the benefit of tirofiban in non-ST-elevation acute coronary syndromes (application of the TIMI risk score for UA/NSTEMI in PRISM-PLUS). Eur Heart J. 2002;23:223–229
  3. Hamm CW, Heeschen C, Goldmann B, et al.  Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med. 1999;340:1623–1629
  4. Morrow DA, Cannon CP, Rifai N, et al.  Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction (results from a randomized trial). JAMA. 2001;286:2405–2412
  5. Morrow DA, Antman EM, Tanasijevic M, et al.  Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina (a TIMI-11B substudy). J Am Coll Cardiol. 2000;36:1812–1817
  6. Jacobs DR, Kroenke C, Crow R, et al.  PREDICT (a simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota Heart Survey). Circulation. 1999;100:599–607
  7. Califf RM, Pieper KS, Lee K, et al.  Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded arteries trial. Circulation. 2000;101:2231–2238
  8. Antman EM, Cohen M, Bernink PJ, et al.  The TIMI risk score for unstable angina/non-ST elevation MI (a method for prognostication and therapeutic decision making). JAMA. 2000;284:835–842
  9. Krumholz HM, Chen J, Chen YT, et al.  Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction (results from the Cooperative Cardiovascular Project). J Am Coll Cardiol. 2001;38:453–459
  10. Granger CB, Goldberg RJ, Dabbous O, et al.  Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med. 2003;163:2345–2353
  11. Boersma E, Pieper KS, Steyerberg EW, et al.  Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation (results from an international trial of 9461 patients). Circulation. 2000;101:2557–2567
  12. Singh M, Reeder GS, Jacobsen SJ, et al.  Scores for post-myocardial infarction risk stratification in the community. Circulation. 2002;106:2309–2314
  13. Rathore SS, Weinfurt KP, Gross CP, et al.  Validity of a simple ST-elevation acute myocardial infarction risk index (are randomized trial prognostic estimates generalizable to elderly patients?). Circulation. 2003;107:811–816
  14. GRACE Investigators . Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project (a multinational registry of patients hospitalized with acute coronary syndromes). Am Heart J. 2001;141:190–199
  15. PURSUIT Trial Investigators . Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 1998;339:436–443
  16. Weintraub W. Prediction scores after myocardial infarction (value, limitations, and future directions). Circulation. 2002;106:2292–2293
  17. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic curve. Radiology. 1982;143:29–36
  18. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839–843
  19. Lemeshow S, Hosmer DW. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115:92–106
  20. Savonitto S, Ardissino D, Granger CB, et al.  Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999;281:707–713
  21. Heidenreich PA, Alloggiamento T, Melsop K, et al.  The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes (a meta-analysis). J Am Coll Cardiol. 2001;38:478–485
  22. Braunwald E, Antman EM, Beasley JW, et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction (a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)). Circulation. 2002;106:1883–1890
  23. Sarnak MJ, Levey AS, Schoolwerth AC, et al.  Kidney disease as a risk factor for the development of cardiovascular disease (a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention). Circulation. 2003;108:2154–2169
  24. McCullough PA, Soman SS, Shah SS, et al.  Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol. 2000;36:679–684
  25. Al Suwaidi J, Reddan DN, Williams K, et al.  Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106:974–980
  26. Khot UN, Jia G, Moliterno DJ, et al.  Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes (the enduring value of Killip classification). JAMA. 2003;290:2174–2181
  27. Brilakis ES, Wright RS, Kopecky SL, et al.  Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction. Am Heart J. 2003;146:811–818
  28. Morrow DA. New insight into clinical risk scores for patients with acute coronary syndromes. Am Heart J. 2003;146:754–756
  29. Scirica BM, Cannon CP, Antman EM, et al.  Validation of the Thrombolysis In Myocardial Infarction (TMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III Registry. Am J Cardiol. 2002;90:303–305

☆ Supported by the Canadian Heart Research Centre and Key Pharmaceuticals, Division of Schering Canada Inc.

PII: S0002-8703(04)00191-7

doi: 10.1016/j.ahj.2004.02.014

American Heart Journal
Volume 148, Issue 6 , Pages 1020-1027 , December 2004

Article Tools

* Image Usage & Resolution